[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
January 5, 2000

Injunction Affecting Abbott's in Vitro Test Devices

Author Affiliations
 

Not Available

Not Available

JAMA. 2000;283(1):46. doi:10.1001/jama.283.1.46

Abbott Laboratories, Abbott Park, Ill, has entered into a consent decree of permanent injunction with the Department of Justice affecting 242 in vitro diagnostic devices manufactured by Abbott's Diagnostic Division in Abbott Park and its K2 facility in North Chicago, Ill. A total of 178 of these devices that the FDA identified as medically necessary continue to be available while their manufacturing is being brought into compliance with the FDA's Quality System regulation; the remaining 64 devices will not be distributed following a transition period to allow users to standardize or obtain alternative test methods.

First Page Preview View Large
First page PDF preview
First page PDF preview
×